Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09SRR
|
|||
| Former ID |
DIB012211
|
|||
| Drug Name |
Unoprostone
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Glaucoma/ocular hypertension [ICD-11: 9C61; ICD-9: 365] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H38O5
|
|||
| Canonical SMILES |
CCCCCCCC(=O)CCC1C(CC(C1CC=CCCCC(=O)O)O)O
|
|||
| InChI |
1S/C22H38O5/c1-2-3-4-5-8-11-17(23)14-15-19-18(20(24)16-21(19)25)12-9-6-7-10-13-22(26)27/h6,9,18-21,24-25H,2-5,7-8,10-16H2,1H3,(H,26,27)/b9-6-/t18-,19-,20+,21-/m1/s1
|
|||
| InChIKey |
TVHAZVBUYQMHBC-SNHXEXRGSA-N
|
|||
| CAS Number |
CAS 120373-36-6
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:39455
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Prostaglandin receptor (PTGR) | Target Info | Modulator | [1], [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | Comparison of the vasoactive effects of the docosanoid unoprostone and selected prostanoids on isolated perfused retinal arterioles. Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1499-504. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.